THERApeutic Outcomes Related to Gut microBIOME in Glioblastoma (GBM) Patients Receiving Chemo-radiation (THERABIOME-GBM)

Clinical trial NCT05326334 · RECRUITING

Trial details

NCT number: NCT05326334
Sponsor: Ottawa Hospital Research Institute
Status: RECRUITING
Study type: OBSERVATIONAL

Glioblastoma, IDH-wildtype

Start date: 2023-03-02
Primary completion: 2025-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.